Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients
Meena Arvindakshan(National Chemical Laboratory), Sahebarao P. Mahadik(Augusta University), Sandhya L. Sitasawad(National Centre for Cell Science), P. K. Ranjekar(National Chemical Laboratory), David F. Horrobin(Nihon University), Madhav R. Ghate(Jawaharlal Nehru Medical College), Vijay B Debsikdar(Institute of Mental Health), C.N. Bennett, Denise R. Evans(Augusta University)
Cited by 233
Related Papers
A Dose-Ranging Study of the Effects of Ethyl-Eicosapentaenoate in Patients With Ongoing Depression Despite Apparently Adequate Treatment With Standard Drugs
|Archives of General Psychiatry|2002|618
Depletion of Omega-3 Fatty Acid Levels in Red Blood Cell Membranes of Depressive Patients
|Biological Psychiatry|1998|583
The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia
|Schizophrenia Research|1998|453
A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms
|Journal of Psychiatric Research|2002|330